The External Scientific Committee of the Research Institute of the Hospital de Santa Creu i Sant Pau – IIB Sant Pau has approved the stabilization of Dra Olivia Belbín and the creation of the emerging Molecular Neurodegeneration research group, led by her, at the proposal of the director of the institute, Dr. Jordi Surrallés.
